To date, three gene mutations are known to cause FH: (1) the LDL receptor itself (FH1); (2) apolipoprotein (apo) B (FH2), a ligand of LDL receptors; and (3) a GOF mutation in PCSK9 (FH3). Here, PCSK9 is linked to familial hyperaldosteronism.